Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver-transplant recipients.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  New England Journal of Medicine

• Publication date

  1994-04-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM199404213301618PMID 8133870
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preliminary experience with alpha-2b-interferon therapy of viral hepatitis in liver allograft recipients.

  1992cited by this paper
• Diagnosis of chronic hepatitis C after liver transplantation by the detection of viral sequences with polymerase chain reaction

  1992cited by this paper
• PRELIMINARY EXPERIENCE WITH α‐2b‐INTERFERON THERAPY OF VIRAL HEPATITIS IN LIVER ALLOGRAFT RECIPIENTS1,2

  1992cited by this paper
• Recurrence of hepatitis C virus infection after orthotopic liver transplantation

  1991cited by this paper
• Expression of class I and class II major histocompatibility complex antigens on human hepatocytes

  1988cited by this paper
• Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients.

  1983cited by this paper

• A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel

  2019cites this paper
• Drugs and Toxins

  2018cites this paper
• Acute vanishing bile duct syndrome after therapy with cephalosporin, metronidazole, and clotrimazole

  2017cites this paper
• Late liver function test abnormalities post-adult liver transplantation: a review of the etiology, investigation, and management

  2015cites this paper
• Chronic Rejection Associated with Antiviral Therapy for Recurrent Hepatitis C after Living-Donor Liver Transplantation

  2014cites this paper
• Hepatotoxicity of antibiotics: a review and update for the clinician.

  2013cites this paper
• Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin.

  2012cites this paper
• 13 – Hepatic injury due to drugs, herbal compounds, chemicals and toxins

  2012cites this paper
• Incidence and Severity of Acute Allograft Rejection in Liver Transplant Recipients Treated With Alfa lnterferon

  2010cites this paper
• 69 Pathology of Liver Transplantation

  2010cites this paper
• Pegylated IFN-α and ribavirin: emerging data in the treatment of special populations

  2009cites this paper
• Transplantation Pathology of the Liver

  2009cites this paper
• Pegylated interferon‐alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantation

  2009cites this paper
• Managing hepatitis C in liver transplant patients with recurrent infection

  2009cites this paper
• Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C

  2009cites this paper
• Evolution of hepatitis C virus in liver allografts

  2009cites this paper
• Effects of Combined IFN-Alpha/Ribavirin Treatment in HCV Disease-Related Progression

  2008cites this paper
• Clinical trial: peg‐interferon alfa‐2b and ribavirin for the treatment of genotype‐1 hepatitis C recurrence after liver transplantation

  2008cites this paper
• Treatment strategy for hepatitis C after liver transplantation.

  2008cites this paper
• Histoire naturelle, prévention et traitement de l'hépatite C après transplantation hépatique

  2008cites this paper
• Antiviral maintenance treatment with interferon and ribavirin for recurrent hepatitis C after liver transplantation: Pilot study

  2007cites this paper
• Chronic Ductopenic Rejection in Patients With Recurrent Hepatitis C Virus Treated With Pegylated Interferon Alfa-2a and Ribavirin

  2007cites this paper
• Rejection Under Alpha Interferon Therapy in Liver Transplant Recipients

  2007influential citation
• Efficacy of an escalating dose regimen of pegylated interferon α‐2a plus ribavirin in the early phase of HCV reinfection after liver transplantation

  2007cites this paper
• Spatulated end‐to‐end bile duct reconstruction in orthotopic liver transplantation

  2007cites this paper
• Aspects of hepatitis C virus infection relating to liver transplantation

  2006cites this paper
• Suivi à court terme (3 mois) après transplantation hépatique chez l'adulte (avec prise en charge du rejet aigu)

  2006cites this paper
• Transplantation and viral hepatitis: major progress

  2006cites this paper
• 69 – Histological Patterns of Rejection and Other Causes of Liver Dysfunction

  2005cites this paper
• The use of stents for duct-to-duct anastomoses of biliary reconstruction in orthotopic liver transplantation.

  2005cites this paper
• Ribavirin/interferon‐α sequential treatment of recurrent hepatitis C after liver transplantation

  2004cites this paper
• Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C

  2004cites this paper
• De novo cryptogenic hepatitis after sustained eradication of hepatitis C following liver transplantation.

  2004cites this paper
• Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores

  2004cites this paper
• Reversible Decompensated Liver Disease as a Possible Complication of Pegylated‐Interferon alfa 2b and Ribavirin for Recurrent Hepatitis C

  2004cites this paper
• Treatment of hepatitis B and C after liver transplantation. Part 1, hepatitis B

  2004cites this paper
• Hepatitis C, interferon, and risk of rejection after liver transplantation

  2004cites this paper
• Acute vanishing bile duct syndrome after ibuprofen therapy in a child.

  2004cites this paper
• Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation

  2004cites this paper
• Outcomes of acute rejection after interferon therapy in liver transplant recipients

  2004cites this paper
• Complete Remission of Metastatic Pancreatic Cancer with Cardiac Involvement after Gemcitabine, Oxaliplatin and 46‐H Infusion of 5‐Fluorouracil/Leucovorin

  2004cites this paper
• Treatment of Hepatitis C in Liver Transplant Patients

  2004cites this paper
• Ribavirin/interferon-α sequential treatment of recurrent hepatitis C after liver transplantation

  2004influential citation
• LETTERS TO THE EDITOR COMPLETE REMISSION OF METASTATIC PANCREATIC CANCER WITH CARDIAC INVOLVEMENT AFTER GEMCITABINE, OXALIPLATIN AND 46-h INFUSION OF 5-FLUOROURACIL/ LEUCOVORIN

  2004cites this paper
• Treatment of hepatitis B and C after liver transplantation. Part 2, hepatitis C

  2004cites this paper
• Treatment of hepatitis C virus infection in the allograft

  2003cites this paper
• Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.

  2003cites this paper
• Traitement de l'hépatite C après greffe hépatique par l'association ribavirine-interféron alpha

  2003cites this paper
• Drugs acting on the immune system

  2003cites this paper
• A patient with hepatitis C-related liver cirrhosis and hepatocellular carcinoma who was cured with an orthotopic liver transplantation and interferon therapy

  2003cites this paper
• The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis1

  2003cites this paper
• [Interferon-alpha and auto-immunity].

  2002cites this paper
• Combination of interferon alfa‐2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C

  2002cites this paper
• Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: Lessons on tolerability and efficacy

  2002cites this paper
• [Natural history, prevention and treatment of hepatitis C virus after liver transplantation].

  2002cites this paper
• Pre‐emptive treatment of recurrent hepatitis C infection

  2002cites this paper
• [Treatment of chronic hepatitis C: side effects, tolerability and quality of life].

  2002cites this paper
• I favor therapy for hepatitis C virus recurrence after transplantation

  2002cites this paper
• [Treatment of hepatitis C after liver transplantation].

  2002cites this paper
• Hepatitis C und Lebertransplantation

  2001cites this paper
• Management of recurrent hepatitis C after liver transplantation

  2001cites this paper
• Hepatitis C and liver transplantation.

  2001cites this paper
• Combination of interferon alfa 2B and ribavirin in liver transplant recipients with histologic recurrent hepatitis C

  2001cites this paper
• Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection.

  2001cites this paper
• Liver transplantation for hepatitis C virus related cirrhosis.

  2000cites this paper
• Posttransplantation prevention and treatment of recurrent hepatitis B

  2000cites this paper
• Hepatitis and solid organ transplantation.

  2000cites this paper
• Hepatitis B and C in the liver transplant recipient.

  2000cites this paper
• Recurrent hepatitis C after liver transplantation

  2000cites this paper
• Interferon Alfa-2A and ribavirin therapy for hepatitis C recurrence after liver transplantation.

  2000cites this paper
• Interferon alpha et auto-immunité

  2000cites this paper
• Hepatitis B and C in the Liver Transplant Recipient

  2000cites this paper
• Posttransplantation prevention and treatment of recurrent hepatitis C

  2000cites this paper
• [Biological monitoring of liver transplantation].

  1999cites this paper
• Treatment strategies for recurrent hepatitis C after liver transplantation.

  1999cites this paper
• Transjugular intrahepatic portosystemic shunt after adult liver transplantation: experience in eight patients.

  1999cites this paper
• Hepatitis C and liver transplantation

  1999cites this paper
• [Role of liver transplantation in the treatment of viral cirrhosis C].

  1999cites this paper
• TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT AFTER ADULT LIVER TRANSPLANTATION

  1999cites this paper
• Treatment of recurrent hepatitis C virus infection after liver transplantation.

  1999cites this paper
• Liver transplantation for viral hepatitis-associated cirrhosis.

  1998cites this paper
• Suivi du transplanté hépatique

  1998cites this paper
• Immune cholangitis: liver allograft rejection and graft-versus-host disease.

  1998cites this paper
• Biliary tract complications of side-to-side without T tube versus end-to-end with or without T tube choledochocholedochostomy in liver transplant recipients.

  1998cites this paper
• Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child.

  1998cites this paper
• [Adult idiopathic ductopenia. 1 case].

  1998cites this paper
• A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation

  1998cites this paper
• Interferons in the management of viral hepatitis.

  1998cites this paper
• Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon.

  1998cites this paper
• [Monitoring of treated or non-treated chronic viral hepatitis C. 2: Criteria of efficacy and monitoring of treatment with interferon-alpha].

  1997cites this paper
• Liver transplantation for hepatitis C‐associated cirrhosis in a single Australian centre: Referral patterns and transplant outcomes

  1997cites this paper
• Liver Transplantation and Hepatitis B

  1997cites this paper
• [How should hepatitis C be monitored? Monitoring of treated hepatitis C].

  1997cites this paper
• Risk of liver retransplantation for viral hepatitis

  1997cites this paper
• Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation

  1997cites this paper
• A trial of high‐dose ursodeoxycholic acid therapy in a liver transplant recipient

  1997cites this paper
• HCV infection and liver transplantation.

  1997cites this paper
• Hepatitis C after orthotopic liver transplantation.

  1997cites this paper
• Cytokine-Induced Autoimmune Disorders

  1997cites this paper
• Hepatitis viruses and liver transplantation

  1997cites this paper